AI startups sell the same shares at two prices

Aaru’s latest funding round did not produce one valuation so much as two. Redpoint put most of its Series A money into the synthetic-customer research startup at a $450 million valuation, then invested a smaller portion at a $1 billion valuation, a structure The Wall Street Journal and TechCrunch report is spreading across hot AI deals.

The mechanism is simple: the same class of equity is sold in the same round at different prices, allowing the company to announce a unicorn headline while the lead investor’s blended entry price is far lower. TechCrunch describes the arrangement as a way to compress what would previously have been two separate financing cycles—an early tranche priced for a large anchor check, followed by a smaller “top-up” tranche priced for the press release and for latecomers who insist on getting in now.

The immediate winners are founders and early backers who need the optics of momentum without the operational cost of perpetual fundraising. A $1 billion headline can help with recruiting—especially when compensation is increasingly equity-heavy—and with enterprise sales, where large customers often treat valuation as a proxy for durability. It also functions as a deterrent: as Primary Ventures partner Jason Shuman tells TechCrunch, a towering headline number can make rival investors think twice before funding the number-two or number-three competitor.

The bill comes due later. If employees are granted options priced off the headline valuation, the company must clear a higher bar to make those options meaningfully in-the-money. And because down rounds are reputationally toxic—often triggering employee repricing demands, partner jitters, and investor protections—the next financing is implicitly expected to land above the $1 billion mark, even if the underlying business performed closer to the blended $450 million reality.

TechCrunch notes the tactic has appeared in other AI financings, including Serval, where Sequoia reportedly received a lower entry price around a $400 million valuation while the company announced a $75 million Series B at $1 billion. The common pattern is oversubscription: rather than turn away smaller funds and strategic investors, companies sell them access at a premium. Those investors accept the terms because the alternative is being excluded from a scarce cap table.

The structure also reflects the stalled IPO pipeline. When there is no near-term public market price discovery, private rounds become narrative instruments, and the “price” becomes an internal negotiation between different constituencies: the lead investor seeking downside protection, the company seeking a headline, and late entrants paying for proximity.

For now, the unicorn label still travels faster than the cap table details. In these deals, the difference is not a rounding error—it is the business model.